MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-07-2025
Fulgent Genetics ROA Ratio 2011-2026 | FLGT
Annual ROA Ratio Fulgent Genetics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.5 | -13.59 | 10.35 | 39.68 | 30.6 | -0.46 | -10.4 | -4.39 | -9.21 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 39.68 | -13.59 | 4.34 |
Quarterly ROA Ratio Fulgent Genetics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.27 | -4.91 | -4.04 | -2.99 | -3.95 | -3.73 | -3.85 | -2.91 | -2.79 | -1.7 | 9.61 | 21.08 | 29.24 | 28.81 | 36.39 | 46.0 | 61.59 | 58.07 | 50.96 | 30.6 | 6.52 | 1.51 | 1.41 | -0.46 | -3.94 | -6.69 | -9.01 | -10.4 | -9.43 | -12.72 | -15.16 | -11.21 | -6.97 | -4.49 | -7.84 | -9.28 | -136.49 | -114.35 | -106.61 | -105.57 | 20.23 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 61.59 | -136.49 | -4.97 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
11.3 | $ 110.3 | -2.8 % | $ 33.5 B |  USA |
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Soleno Therapeutics
SLNO
|
3.71 | $ 30.28 | -4.87 % | $ 1.54 B | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | USA |
 |
Neuronetics
STIM
|
-27.55 | $ 1.4 | 4.89 % | $ 92.3 M | USA |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Sotera Health Company
SHC
|
2.39 | $ 13.25 | -2.18 % | $ 3.76 B | USA |
 |
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M |  Israel |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
Trinity Biotech plc
TRIB
|
0.78 | $ 0.61 | -0.7 % | $ 61.9 M |  Irlanda |
 |
BioNano Genomics
BNGO
|
-35.87 | $ 1.15 | - | $ 6.26 M | USA |
 |
Twist Bioscience Corporation
TWST
|
-12.1 | $ 44.54 | -4.74 % | $ 2.66 B | USA |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Castle Biosciences
CSTL
|
3.43 | $ 23.99 | -2.87 % | $ 666 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 159.38 | -3.48 % | $ 7.9 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
6.11 | $ 196.09 | -1.04 % | $ 21.8 B | USA |
 |
Organovo Holdings
ONVO
|
-16.98 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
121.6 | - | -16.95 % | $ 1.54 M | USA |
 |
DarioHealth Corp.
DRIO
|
-37.9 | $ 8.45 | - | $ 33.7 M | Israel |
 |
Waters Corporation
WAT
|
12.66 | $ 289.91 | -3.54 % | $ 17.3 B | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
-19.4 | $ 117.59 | -5.48 % | $ 18.7 B | USA |
 |
PerkinElmer
PKI
|
1.98 | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
-5.11 | - | - | $ 21.2 M | USA |
 |
Interpace Biosciences
IDXG
|
45.31 | $ 1.68 | -2.89 % | $ 7.37 M | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
1.47 | - | - | $ 10.6 B |  Niderland |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 8.85 | -3.33 % | $ 1.92 B | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Personalis
PSNL
|
-30.08 | $ 6.33 | -13.59 % | $ 375 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 264.96 | -1.27 % | $ 22 B | USA |
 |
Senseonics Holdings
SENS
|
-54.73 | $ 6.45 | -1.68 % | $ 269 M | USA |
 |
Psychemedics Corporation
PMD
|
-33.7 | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
-32.34 | $ 25.68 | -3.24 % | $ 33.3 M | USA |
 |
CareDx, Inc
CDNA
|
-5.17 | $ 16.68 | -4.52 % | $ 889 M | USA |
 |
Quotient Limited
QTNT
|
-50.51 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Syneos Health
SYNH
|
2.85 | - | - | $ 4.46 B | USA |
 |
Renalytix AI plc
RNLX
|
-419.67 | - | 5.66 % | $ 22.7 M | Britain |
 |
VolitionRx Limited
VNRX
|
-289.99 | $ 0.2 | 1.97 % | $ 19.2 M |  Singapore |
|
Biodesix
BDSX
|
-44.15 | $ 14.27 | -2.26 % | $ 1.85 B | USA |